What is VDx?
VDx Diagnostics is a prominent provider of expert analysis for biopsy and cytology samples, crucial for veterinary clinicians in diagnosing and treating animal patients. Beyond its core veterinary services, the company extends its histopathology and pathology support to the medical device, biotech, pharmaceutical, academic, and broader veterinary communities. With over two decades of experience, VDx has cultivated a reputation for diagnostic excellence, operational reliability, and client satisfaction, primarily serving Northern California and the Western United States. Its team of board-certified pathologists is dedicated to delivering high-quality diagnostic services and comprehensive reporting, reinforcing its role as a key player in the animal health and diagnostic support industry.
How much funding has VDx raised?
VDx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in VDx
PPP
Public-Private Partnership
What's next for VDx?
The substantial late-stage funding and recent strategic investment signal a pivotal moment for VDx. This capital infusion is likely earmarked for scaling operations, expanding service offerings, and potentially enhancing technological capabilities in diagnostic analysis. The company's focus on specialized veterinary pathology, coupled with its support for related industries, positions it for continued growth and innovation. Future strategic moves may involve geographic expansion, further integration of advanced diagnostic technologies, or strategic partnerships to broaden its market reach and solidify its leadership in the veterinary diagnostics landscape.
See full VDx company page
